Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms | MicrobiomeTrials← Back to trialsNCT01005654
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
RecruitingOBSERVATIONAL
Trial Details
Enrollment target: 2,415 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Ovarian Cancer RecurrentOvarian CancerPlatinum Resistant Ovarian Cancer
The goal of this clinical trial is to learn if OPB-101 is safe in platinum resistant ovarian cancer participants and als…
Detroit, United StatesCompleted Sep 30, 2026
Colorectal NeoplasmsNeoplasmsIntrahepatic CholangiocarcinomaAdrenocortical CarcinomaMetastasis, Neoplasm
Background:
Cancers that begin in the colon, adrenal glands, or bile ducts may spread to the liver. These liver tumors …
Bethesda, United StatesEst. completion Dec 31, 2029
Lymphoplasmacytic LymphomaWaldenstrom Macroglobulinemia
This phase II trial studies the effects of venetoclax and rituximab in comparison to ibrutinib and rituximab or zanubrut…
Tucson, United StatesEst. completion Mar 31, 2028